Outcomes of Combined iStent Trabecular Micro-Bypass and Cataract Surgery for the Treatment of Open-Angle Glaucoma in a Saudi Population

References

• Quigley HA, Broman AT. The number of people with glaucoma world wide in 2010 and 2020. Br J Ophthalmol. 2006;90:262–267. doi:10.1136/bjo.2005.081224
   PubMed Web of Science ®Google Scholar
• Tabbara KF, Ross-Degnan D. Blindness in Saudi Arabia. JAMA. 1986;255:3378–3384. doi:10.1001/jama.1986.03370240048035
   PubMed Web of Science ®Google Scholar
• Cook C, Foster P. Epidemiology of glaucoma: what’s new? Can J Ophthalmol. 2012;47(3):223–226. doi:10.1016/j.jcjo.2012.02.003
   PubMed Web of Science ®Google Scholar
• Leske MC, Heijl A, Hussein M, et al. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol. 2003;121(1):48–56. doi:10.1001/archopht.121.1.48
   PubMedGoogle Scholar
• Prum BE Jr, Rosenberg LF, Gedde SJ, et al. Primary open-angle glaucoma preferred practice pattern guidelines. Ophthalmology. 2016;123:P41–P111. doi:10.1016/j.ophtha.2015.10.053
   PubMed Web of Science ®Google Scholar
• Tsai JC. A comprehensive perspective on patient adherence to topical glaucoma therapy. Ophthalmology. 2009;116:S30–S36. doi:10.1016/j.ophtha.2009.06.024
   PubMed Web of Science ®Google Scholar
• Juzych MS, Chopra V, Banitt MR, et al. Comparison of long-term outcomes of selective laser trabeculoplasty versus argon laser trabeculoplasty in open-angle glaucoma. Ophthalmology. 2004;111(10):1853–1859. doi:10.1016/j.ophtha.2004.04.030
   PubMed Web of Science ®Google Scholar
• Laser Trial Research Group G; Glaucoma Laser Trial Research Group. The Glaucoma Laser Trial (GLT) and glaucoma laser trial follow-up study: 7. Results. Am J Ophthalmol. 1995;120(6):718–731. doi:10.1016/S0002-9394(14)72725-4
   PubMed Web of Science ®Google Scholar
• Gedde SJ, Herndon LW, Brandt JD, Budenz DL, Feuer WJ, Schiffman JC. Tube Versus Trabeculectomy Study Group. Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up. Am J Ophthalmol. 2012;153(5):804–814. doi:10.1016/j.ajo.2011.10.024
   PubMed Web of Science ®Google Scholar
• Saheb H, Ahmed IIK. Micro-invasive glaucoma surgery: current perspectives and future directions. Curr Opin Ophthalmol. 2012;23:96–104. doi:10.1097/ICU.0b013e32834ff1e7
   PubMed Web of Science ®Google Scholar
• Chen KH, Kim WI. Implantation of a CyPass supraciliary stent combined with targeted iStent trabecular microbypass stents in a phakic patient with primary open-angle glaucoma. J Glaucoma. 2018;27(2):e37–e39. doi:10.1097/IJG.0000000000000835
   Web of Science ®Google Scholar
• Lynn SC FDA approves first glaucoma stent for use with cataract surgery. FDA Press Announcements [Internet]. Jun 2, 2012. [cited May 4, 2016]. Available from http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm309667.htm.
   Google Scholar
• Grant WM. Experimental aqueous perfusion in enucleated human eyes. Arch Ophthalmol. 1963;69(6):783–801. doi:10.1001/archopht.1963.00960040789022
   PubMedGoogle Scholar
• Ethier CR, Kamm RD, Palaszewski BA, Johnson MC, Richardson TM. Calculations of flow resistance in the juxtacanalicular meshwork. Invest Ophthalmol Vis Sci. 1986;27(12):1741–1750.
   Web of Science ®Google Scholar
• Nichamin LD. Glaukos iStent® trabecular micro-bypass. Middle East Afr J Ophthalmol. 2009;16(3):138–140. doi:10.4103/0974-9233.56227
   PubMedGoogle Scholar
• Fernandez-Barrientos Y, Garcia-Feijoo J, Martinez-de-la-Casa JM, et al. Fluorophotometric study of the effect of the glaukos trabecular microbypass stent on aqueous humor dynamics. Invest Ophthalmol Vis Sci. 2010;51(7):3327–3332. doi:10.1167/iovs.09-3972
   PubMed Web of Science ®Google Scholar
• Fea AM, Consolandi G, Zola M, et al. Micro-bypass implantation for primary open-angle glaucoma combined with phacoemulsification: 4-year follow-up. J Ophthalmol. 2015;2015:795357. doi:10.1155/2015/795357
   PubMed Web of Science ®Google Scholar
• Buffet J, Brasnu E, Baudouin C, Labb_e A. Efficacy of 2 trabecular micro-bypass stents during phacoemulsification for mild to advanced primary open-angle glaucoma controlled with topical hypotensive medications. J Glaucoma. 2017;26(12):1149–1154. doi:10.1097/IJG.0000000000000808
   Web of Science ®Google Scholar
• Ferguson TJ, Swan R, Ibach M, Schweitzer J, Sudhagoni R, Berdahl JP. Trabecular microbypass stent implantation with cataract extraction in pseudoexfoliation glaucoma. J Cataract Refract Surg. 2017;43(5):622–626. doi:10.1016/j.jcrs.2017.02.029
   PubMed Web of Science ®Google Scholar
• Ferguson TJ, Berdahl JP, Schweitzer JA, Sudhagoni RG. Clinical evaluation of a trabecular micro-bypass stent with phacoemulsification in patients with open-angle glaucoma and cataract. Clin Ophthalmol. 2016;10:1767–1773. doi:10.2147/OPTH.S114306
   PubMed Web of Science ®Google Scholar
• Craven ER, Katz LJ, Wells JM, Giamporcaro JE. Cataract surgery with trabecular micro-bypass stent implantation in patients with mild-to-moderate open-angle glaucoma and cataract: two-year follow-up. J Cataract Refract Surg. 2012;38:1339–1345. doi:10.1016/j.jcrs.2012.03.025
   PubMed Web of Science ®Google Scholar
• Seibold LK, Gamett KM, Kennedy JB, et al. Outcomes after combined phacoemulsification and trabecular microbypass stent implantation in controlled open angle glaucoma. J Cataract Refract Surg. 2016;42:1332–1338. doi:10.1016/j.jcrs.2016.07.023
   Web of Science ®Google Scholar
• Neuhann TH, Hornbeak DM, Neuhann RT, Giamporcaro JE. Long-term effectiveness and safety of trabecular microbypass stent implantation with cataract surgery in patients with glaucoma or ocular hypertension: five-year outcomes. J Cataract Refract Surg. 2018;45(3):312–320. doi:10.1016/j.jcrs.2018.10.029
   Web of Science ®Google Scholar
• Inoue K. Managing adverse effects of glaucoma medications. Clin Ophthalmol. 2014;8:903–913. doi:10.2147/OPTH.S44708
   PubMedGoogle Scholar
• Patel V, Ahmed I, Podbielski D, Falvey H, Murray J, Goeree R. Cost-effectiveness analysis of standalone trabecular micro-bypass stents in patients with mild-to-moderate open-angle glaucoma in Canada. J Med Econ. 2019;22(4):390–401. doi:10.1080/13696998.2019.1572013
   PubMed Web of Science ®Google Scholar
• Ngan K, Fraser E, Buller S, Buller A. A cost minimisation analysis comparing iStent accompanying cataract surgery and selective laser trabeculoplasty versus topical glaucoma medications in a public healthcare setting in New Zealand. Graefes Arch Clin Exp Ophthalmol. 2018;256(11):2181–2189.
   PubMed Web of Science ®Google Scholar
• Yasir ZH, Chauhan D, Khandekar R, Souru C, Varghese S. Prevalence and determinants of dry eye disease among 40 years and older population of Riyadh (except capital), Saudi Arabia. Middle East Afr J Ophthalmol. 2019;26(1):27–32. doi:10.4103/meajo.MEAJO_194_18
   PubMed Web of Science ®Google Scholar
• Alshamrani AA, Almousa AS, Almulhim AA, et al. Prevalence and risk factors of dry eye symptoms in a Saudi Arabian population. Middle East Afr J Ophthalmol. 2017;24(2):67–73. doi:10.4103/meajo.MEAJO_281_16
   PubMed Web of Science ®Google Scholar
• Broadway DC, Grierson I, O’Brien C, Hitchings RA. Adverse effects of topical antiglaucoma medication: II. The outcome of filtration surgery. Arch Ophthalmol. 1994;112(11):1446–1454. doi:10.1001/archopht.1994.01090230060021
   PubMedGoogle Scholar
• Samuelson TW, Katz LJ, Wells JM, Duh Y-J, Giamporcaro JE. Randomized evaluation of the trabecular micro-bypass stent with phacoemulsification in patients with glaucoma and cataract. Ophthalmology. 2011;118:459–467. doi:10.1016/j.ophtha.2010.07.007
   PubMed Web of Science ®Google Scholar
• Chang DF, Donnenfeld ED, Katz LJ, et al. Efficacy of two trabecular micro-bypass stents combined with topical travoprost in open-angle glaucoma not controlled on two preoperative medications: 3-year follow-up. Clin Ophthalmol. 2017;11:523–528. doi:10.2147/OPTH.S121041
   PubMed Web of Science ®Google Scholar
• Iordanous Y, Hutnik CML, Malvankar M. Cost-effectiveness analysis of iStent and phacoemulsification versus glaucoma medications in the Ontario Health Insurance Plan (OHIP). Invest Ophthalmol Vis Sci. 2014;55(13):5595.
   Web of Science ®Google Scholar
• Vizzeri G, Weinreb RN. Cataract surgery and glaucoma. Curr Opin Ophthalmol. 2010;21(1):20–24. doi:10.1097/ICU.0b013e328332f562
   PubMed Web of Science ®Google Scholar
• Fea AM. Phacoemulsification versus phacoemulsification with micro-bypass stent implantation in primary open-angle glaucoma: randomized double-masked clinical trial. J Cataract Refract Surg. 2010;36:407–412. doi:10.1016/j.jcrs.2009.10.031
   PubMed Web of Science ®Google Scholar